|
1
|
Miller AJ and Mihm MC Jr: Melanoma. N Engl
J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karin M and Lin A: NF-kappaB at the
crossroads of life and death. Nat Immunol. 3:221–227. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamata H, Honda S, Maeda S, Chang L,
Hirata H and Karin M: Reactive oxygen species promote
TNFalpha-induced death and sustained JNK activation by inhibiting
MAP kinase phosphatases. Cell. 120:649–661. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kataoka T: The caspase-8 modulator c-FLIP.
Crit Rev Immunol. 25:31–58. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang DW, Xing Z, Pan Y,
Algeciras-Schimnich A, Barnhart BC, Yaish-Ohad S, Peter ME and Yang
X: c-FLIP(L) is a dual function regulator for caspase-8 activation
and CD95-mediated apoptosis. EMBO J. 21:3704–3714. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Safa AR: c-FLIP, a master anti-apoptotic
regulator. Exp Oncol. 34:176–184. 2012.PubMed/NCBI
|
|
7
|
Safa AR and Pollok KE: Targeting the
anti-apoptotic protein c-FLIP for cancer therapy. Cancers (Basel).
3:1639–1671. 2011. View Article : Google Scholar
|
|
8
|
Wall NR and Shi Y: Small RNA: Can RNA
interference be exploited for therapy? Lancet. 362:1401–1403. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Medarova Z, Pham W, Farrar C, Petkova V
and Moore A: In vivo imaging of siRNA delivery and silencing in
tumors. Nat Med. 13:372–377. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen HL, Xu W, Wu ZY, Zhou LL, Qin RJ and
Tang HR: Vector-based RNAi approach to isoform-specific
down-regulation of vascular endothelial growth factor (VEGF) 165
expression in human leukemia cells. Leuk Res. 31:515–521. 2007.
View Article : Google Scholar
|
|
11
|
Sakon S, Xue X, Takekawa M, Sasazuki T,
Okazaki T, Kojima Y, Piao JH, Yagita H, Okumura K, Doi T and Nakano
H: NF-kappaB inhibits TNF-induced accumulation of ROS that mediate
prolonged MAPK activation and necrotic cell death. EMBO J.
22:3898–3909. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tian F, Lu JJ, Wang L, Li L, Yang J, Li Y,
Liu YQ, Shen GX, Tu YT and Tao J: Expression of c-FLIP in malignant
melanoma and its relationship with the clinicopathological features
of the disease. Clin Exp Dermatol. 37:259–265. 2012. View Article : Google Scholar
|
|
13
|
Mori T, Doi R, Toyoda E, Koizumi M, Ito D,
Kami K, Kida A, Masui T, Kawaguchi Y and Fujimoto K: Regulation of
the resistance to TRAIL-induced apoptosis as a new strategy for
pancreatic cancer. Surgery. 138:71–77. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dutton A, O'Neil JD, Milner AE, Reynolds
GM, Starczynski J, Crocker J, Young LS and Murray PG: Expression of
the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's
lymphoma cells from autonomous Fas-mediated death. Proc Natl Acad
Sci USA. 101:6611–6616. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abedini MR, Qiu Q, Yan X and Tsang BK:
Possible role of FLICE-like inhibitory protein (FLIP) in
chemoresistant ovarian cancer cells in vitro. Oncogene.
23:6997–7004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mezzanzanica D, Balladore E, Turatti F,
Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F,
Oggionni M, et al: CD95-mediated apoptosis is impaired at receptor
level by cellular FLICE-inhibitory protein (long form) in wild-type
p53 human ovarian carcinoma. Clin Cancer Res. 10:5202–5214. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Safa AR: Roles of c-FLIP in apoptosis,
necroptosis, and autophagy. J Carcinog Mutagen. (Suppl 6):
0032013.PubMed/NCBI
|
|
18
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanisms of apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weston CR and Davis RJ: The JNK signal
transduction pathway. Curr Opin Cell Biol. 19:142–149. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bubici C and Papa S: JNK signalling in
cancer: In need of new, smarter therapeutic targets. Br J
Pharmacol. 171:24–37. 2014. View Article : Google Scholar :
|
|
22
|
Uzdensky AB, Demyanenko SV and Bibov MY:
Signal transduction in human cutaneous melanoma and target drugs.
Curr Cancer Drug Targets. 13:843–866. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dhanasekaran DN and Reddy EP: JNK
signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jørgensen K, Davidson B and Flørenes VA:
Activation of c-jun N-terminal kinase is associated with cell
proliferation and shorter relapse-free period in superficial
spreading malignant melanoma. Mod Pathol. 19:1446–1455.
2006.PubMed/NCBI
|
|
25
|
Day TW, Huang S and Safa AR: C-FLIP
knockdown induces ligand-independent DR5-, FADD-, caspase-8- and
caspase-9-dependent apoptosis in breast cancer cells. Biochem
Pharmacol. 76:1694–1704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sharp DA, Lawrence DA and Ashkenazi A:
Selective knockdown of the long variant of cellular FLICE
inhibitory protein augments death receptor-mediated caspase-8
activation and apoptosis. J Biol Chem. 280:19401–19409. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wilson TR, McLaughlin KM, McEwan M, Sakai
H, Rogers KM, Redmond KM, Johnston PG and Longley DB: C-FLIP: A key
regulator of colorectal cancer cell death. Cancer Res.
67:5754–5762. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wilson C, Wilson T, Johnston PG, Longley
DB and Waugh DJ: Interleukin-8 signaling attenuates TRAIL- and
chemotherapy-induced apoptosis through transcriptional regulation
of c-FLIP in prostate cancer cells. Mol Cancer Ther. 7:2649–2661.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park D, Shim E, Kim Y, Kim YM, Lee H, Choe
J, Kang D, Lee YS and Jeoung D: C-FLIP promotes the motility of
cancer cells by activating FAK and ERK and increasing MMP-9
expression. Mol Cells. 25:184–195. 2008.PubMed/NCBI
|
|
30
|
Naito M, Katayama R, Ishioka T, Suga A,
Takubo K, Nanjo M, Hashimoto C, Taira M, Takada S, Takada R, et al:
Cellular FLIP inhibits beta-catenin ubiquitylation and enhances Wnt
signaling. Mol Cell Biol. 24:8418–8427. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimada K, Nakamura M, Ishida E, Kishi M,
Matsuyoshi S and Konishi N: The molecular mechanism of
sensitization to Fas-mediated apoptosis by 2-methoxyestradiol in
PC3 prostate cancer cells. Mol Carcinog. 39:1–9. 2004. View Article : Google Scholar
|
|
32
|
Wang W, Wang S, Song X, Sima N, Xu X, Luo
A, Chen G, Deng D, Xu Q, Meng L, et al: The relationship between
c-FLIP expression and human papillomavirus E2 gene disruption in
cervical carcinogenesis. Gynecol Oncol. 105:571–577. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen HX, Liu YJ, Zhou XD and Luo RY:
Expression of cellular FLICE/caspase-8 inhibitory protein is
associated with malignant potential in endometrial carcinoma. Int J
Gynecol Cancer. 15:663–670. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakajima A, Komazawa-Sakon S, Takekawa M,
Sasazuki T, Yeh WC, Yagita H, Okumura K and Nakano H: An
antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits
the JNK pathway. EMBO J. 25:5549–5559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakajima A, Kojima Y, Nakayama M, Yagita
H, Okumura K and Nakano H: Downregulation of c-FLIP promotes
caspase-dependent JNK activation and reactive oxygen species
accumulation in tumor cells. Oncogene. 27:76–84. 2008. View Article : Google Scholar
|
